SCHEMBL6982507

SCHEMBL6982507

Clc1nccc(Nc2ccc(N3CCOCC3)cc2)n1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLK4 O00444 4/20 0.67
▸ AURKA O14965 2/20 0.62
▸ AURKB Q96GD4 1/20 0.62
▸ KDR P35968 2/20 0.56
▸ IGF1R P08069 3/20 0.56
▸ EPHB4 P54760 1/20 0.54
▸ MAPK10 P53779 2/20 0.53
▸ JAK2 O60674 2/20 0.53
▸ JAK3 P52333 1/20 0.53
▸ KDM4E B2RXH2 1/20 0.52
▸ MEN1 O00255 1/20 0.52
▸ MAPT P10636 1/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ KMT2A Q03164 1/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ PLK1 P53350 1/20 0.52
▸ MAPK8 P45983 1/20 0.52
▸ RAF1 P04049 1/20 0.51
▸ PDGFRB P09619 1/20 0.51
▸ KIT P10721 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23887632 0.91 PLK4 (0.74) PLK4AURKAAURKBIGF1REPHB4
SCHEMBL6968717 0.85 BRD4 (0.61) PLK4KDRJAK2JAK3SLC2A1
SCHEMBL30749035 0.84 MAPK14 (0.52) PLK4AURKAAURKBIGF1RMEN1
SCHEMBL16423491 0.81 PLK4 (0.70) PLK4AURKAAURKBIGF1REPHB4
SCHEMBL15918396 0.80 PLK4 (0.61) PLK4AURKAAURKBJAK2JAK3
SCHEMBL20529569 0.79 PLK4 (0.72) PLK4AURKAAURKBKDRIGF1R
SCHEMBL28053893 0.79 ALK (0.63) PLK4AURKAAURKBKDRIGF1R
SCHEMBL28965359 0.78 PLK4 (0.57) PLK4AURKAAURKBIGF1REPHB4
SCHEMBL3214863 0.78 PLK4 (0.69) PLK4AURKAAURKBIGF1REPHB4
SCHEMBL2061358 0.78 MAPT (0.62) AURKAAURKBIGF1RMAPK10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0862560-B1 SUBSTITUTED 2-ANILINOPYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS CELLTECH THERAPEUTICS LTD (GB) 2003-04-02 — — EP disclosed
US-6235746-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATIVE AGENT CELLTECH THERAPEUTICS, LIMITED (GB) 2001-05-22 — — US disclosed
US-5958935-A Substituted 2-anilinopyrimidines useful as protein kinase inhibitors CELLTECH THERAPEUTICS LIMITED (GB) 1999-09-28 — — US disclosed
EP-0862560-A1 SUBSTITUTED 2-ANILINOPYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS CELLTECH THERAPEUTICS LIMITED (GB) 1998-09-09 — — EP disclosed
WO-1997019065-A1 SUBSTITUTED 2-ANILINOPYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS CELLTECH THERAPEUTICS LIMITED (GB) 1997-05-29 — — WO disclosed
Send feedback